OBJECTIVE: To report a case of probable pentamidine-induced acute panc
reatitis. CASE SUMMARY: A patient was hospitalized because of fever, d
yspnea, and productive cough. Chest X-ray revealed diffuse alveolar in
filtrates, and the examination of bronchoalveolar lavage demonstrated
the presence of Pneumocystis carinii. Intravenous co-trimoxazole was a
dministered but the patient's condition did not improve. As secondary
leukopenia appeared, the treatment was changed to pentamidine isethion
ate 4 mg/kg/d iv. On day 5 of this new therapy, the patient experience
d abdominal pain, and both blood and urine amylase concentrations rais
ed to 330 U/L and 3960 U/L, respectively. The patient died 48 hours ta
ter, and signs of acute pancreatitis were observed in necropsy. DISCUS
SION: With reference to a classical method for estimating the probabil
ity of adverse drug reactions, a probable relationship between pentami
dine therapy and acute pancreatitis was found in this patient. Further
more, no alternative causes of pancreatitis were present. CONCLUSIONS:
It is likely that pentamidine administration in our patient resulted
in an acute episode of pancreatitis. Serum and urine amylase concentra
tions should be monitored in patients receiving this drug.